NCT03365947 - Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) | Biotech Hunter

Enrollment

114

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

April 23, 2020

Study Completion Date

April 23, 2020

Conditions

Hepatitis B

Interventions

DRUG

ARO-HBV

sc injection

OTHER

Sterile Normal Saline (0.9% NaCl)

sc injection

DRUG

JNJ-56136379

oral tablets

Trial Locations (7)

Research Site 1, Grafton

Research Site 2, Papatoetoe

Research Site 5, Camperdown

Research Site 3, Melbourne

Research Site 4, Clayton

Research Site 6, Nedlands

Research Site 7, Hong Kong